510(k) K983841

BIOTEST ANTI-EBV RECOMBINANT, EBNA IGG by Biotest Diagnostics Corp. — Product Code LSE

K983841 is an FDA 510(k) premarket notification submitted by Biotest Diagnostics Corp. for the device "BIOTEST ANTI-EBV RECOMBINANT, EBNA IGG". The FDA issued a decision of Substantially Equivalent on Jun 9, 1999. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Biotest Diagnostics Corp. has 4 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jun 9, 1999
Date Received
Oct 30, 1998
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Epstein-Barr Virus, Other
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Biotest Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K983841. Report a data issue: hello@regdatalab.com.